Related Experiment Video
Updated: Jul 4, 2025

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
Published on: August 14, 2019
[PHYTOTHERAPY AND NATURAL AGENTS IN SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA (BPH)]
Menachem Laufer1, Shir Shoenfeld2
1Department of Urology, Chaim Sheba Medical Center.
Benign prostatic hyperplasia (BPH) affects many older men. This review covers herbal medicines used worldwide for BPH symptoms, with Serenoa repens showing strong clinical support.
Area of Science:
- Urology
- Pharmacology
- Herbal Medicine
Background:
- Benign prostatic hyperplasia (BPH) is a prevalent condition in men over 50, often requiring treatment for urinary symptoms.
- While conventional therapies like alpha-blockers and 5-ARIs exist, many men seek alternative treatments, including herbal medicines.
- This review focuses on globally used herbs for symptomatic BPH, examining their laboratory and clinical evidence.
Approach:
- Systematic review of scientific literature on herbal remedies for BPH.
- Analysis of laboratory data and clinical trial results for various herbs.
- Evaluation of the evidence supporting the use of specific herbal interventions.
Key Points:
- Numerous herbs are used worldwide for symptomatic BPH, with varying degrees of scientific backing.
- Mechanisms of action for many herbal treatments remain unclear, but clinical benefits are observed.
- Serenoa repens (hexanic extract, Permixon) is highlighted as the only herbal medicine with robust clinical trial data supporting its efficacy.
Conclusions:
- Herbal medicines represent a significant alternative treatment avenue for men with symptomatic BPH.
- Further research is needed to elucidate the mechanisms of action for most herbs used in BPH management.
- Serenoa repens demonstrates the most compelling evidence among herbal options for treating BPH symptoms.
More Related Videos
06:04Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
Published on: March 6, 2018
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...